<SEC-DOCUMENT>0001387131-20-003271.txt : 20200326
<SEC-HEADER>0001387131-20-003271.hdr.sgml : 20200326
<ACCEPTANCE-DATETIME>20200326160658
ACCESSION NUMBER:		0001387131-20-003271
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20200326
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200326
DATE AS OF CHANGE:		20200326

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TherapeuticsMD, Inc.
		CENTRAL INDEX KEY:			0000025743
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870233535
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00100
		FILM NUMBER:		20746205

	BUSINESS ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431
		BUSINESS PHONE:		561-961-1900

	MAIL ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMHN, Inc.
		DATE OF NAME CHANGE:	20090930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF ENTERPRISES INC
		DATE OF NAME CHANGE:	19970915

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF OIL CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>txmd-8k_032620.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:TXMD="http://therapeuticsmd.com/20200326">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" /></head>
<!-- Field: Set; Name: xdx; ID: xdx_021_US%2DGAAP%2D2019 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_TXMD_therapeuticsmd.com_20200326 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20200326_20200326 -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0000025743 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body>
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityCentralIndexKey">0000025743</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-03-26to2020-03-26" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="txmd-20200326.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-03-26to2020-03-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000025743</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-26</xbrli:startDate>
        <xbrli:endDate>2020-03-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM <span id="xdx_90D_edei--DocumentType_c20200326__20200326_zOTjuoAddsx3"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (date of earliest event reported):
<span id="xdx_903_edei--DocumentPeriodEndDate_c20200326__20200326_zn59z4zMKrR"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 26, 2020</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_903_edei--EntityRegistrantName_c20200326__20200326_z8llenwnZihd"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityRegistrantName">TherapeuticsMD, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact Name of Registrant as Specified in Its
Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 32%; text-align: center"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20200326__20200326_zJiqNZrbYzrh"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 32%; text-align: center"><b><span id="xdx_90A_edei--EntityFileNumber_c20200326__20200326_zajfaKPIvJo9"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityFileNumber">001-00100</ix:nonNumeric></span></b></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 32%; text-align: center"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20200326__20200326_z6uex6KQ3W0h"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityTaxIdentificationNumber">87-0233535</ix:nonNumeric></span></b></td></tr>
<tr>
    <td style="vertical-align: top">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or Other Jurisdiction of</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Incorporation)</p></td>
    <td>&#160;</td>
    <td style="vertical-align: top">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Commission File</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Number)</p></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center">(IRS Employer Identification No.)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 20%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 60%; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20200326__20200326_zuJXHqMQn4jc"><span id="xdx_90F_edei--EntityAddressAddressLine1_c20200326__20200326_zkAql5BvcQEd"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityAddressAddressLine1"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityAddressAddressLine1">951 Yamato Road</ix:nonNumeric></ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20200326__20200326_zQH3lbpgBGWa"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityAddressAddressLine2">Suite 220</ix:nonNumeric></span></span></b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b><span id="xdx_904_edei--EntityAddressCityOrTown_c20200326__20200326_zwzElEzELyDd"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityAddressCityOrTown">Boca Raton</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20200326__20200326_ziCZPuKy0F2d"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityAddressStateOrProvince">FL</ix:nonNumeric></span> <span id="xdx_90D_edei--EntityAddressPostalZipCode_c20200326__20200326_z90ljjM1txf5"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityAddressPostalZipCode">33431</ix:nonNumeric></span></b></p></td>
    <td style="vertical-align: bottom; width: 20%; text-align: center">&#160;</td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: top; padding-left: 12.1pt; text-align: center">(Address of principal executive office) (zip code)</td>
    <td style="vertical-align: bottom; padding-left: 12.1pt; text-align: center">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <span id="xdx_908_edei--CityAreaCode_c20200326__20200326_zTghdTLku5j3"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:CityAreaCode">(561)</ix:nonNumeric></span> <span id="xdx_908_edei--LocalPhoneNumber_c20200326__20200326_zimGUuS7xG0k"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:LocalPhoneNumber">961-1900</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 100%; text-align: center"><span id="xdx_902_edei--EntityInformationFormerLegalOrRegisteredName_c20200326__20200326_zX9LjgOqSuf1"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:EntityInformationFormerLegalOrRegisteredName">Not Applicable</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 12.1pt; text-align: center">(Former name or former address, if changed since last report.)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial Unicode MS,sans-serif"><span id="xdx_904_edei--WrittenCommunications_c20200326__20200326_ztRBMYFjPVJ"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span>
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial Unicode MS,sans-serif"><span id="xdx_907_edei--SolicitingMaterial_c20200326__20200326_zkLfqiCx6Xra"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial Unicode MS,sans-serif"><span id="xdx_909_edei--PreCommencementTenderOffer_c20200326__20200326_zgjqpPAwAJE6"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial Unicode MS,sans-serif"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20200326__20200326_zIHyv5xPMfza"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Securities registered pursuant to Section 12(b) of the Act:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border: Black 1pt solid; width: 40%; padding-top: 3pt; padding-bottom: 3pt; text-align: center">Title of each class</td>
    <td style="border-top: Black 1pt solid; width: 20%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center">Trading Symbol</td>
    <td style="border-top: Black 1pt solid; width: 40%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center">Name of each exchange on which registered</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><b><span id="xdx_90B_edei--Security12bTitle_c20200326__20200326_zUkaUeqh5m8k"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></b></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><b><span id="xdx_900_edei--TradingSymbol_c20200326__20200326_zQASGaQEsA52"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" name="dei:TradingSymbol">TXMD</ix:nonNumeric></span></b></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><b><span id="xdx_90A_edei--SecurityExchangeName_c20200326__20200326_zWv4fpHzmgEk"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Emerging growth company &#160;&#160;&#160;&#160;<span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_900_edei--EntityEmergingGrowthCompany_c20200326__20200326_zU3kB4EjaEya"><ix:nonNumeric contextRef="From2020-03-26to2020-03-26" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;&#160;<span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 10%"><span style="color: #212529"><b>Item 7.01</b></span></td>
    <td style="width: 90%"><span style="color: #212529"><b>Regulation FD Disclosure.</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"><i>COVID-19 (coronavirus)
Business Update</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">On
March 26, 2020, TherapeuticsMD, Inc., a Nevada corporation (the &#8220;Company&#8221;), issued a press release providing a
business update, including announcing the suspension of the Company&#8217;s previously issued 2020 financial guidance due to
the unknown impact of COVID-19 (coronavirus) on the Company&#8217;s business operations. The Company is unable to predict the
impact of the COVID-19 pandemic on its financial results for 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529; text-indent: 0.5in">A copy
of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The
information furnished in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 hereto, shall not be deemed
to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to
the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"><i>Mitchell Krassan 10b5-1
Trading Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">On
March 23, 2020, Mitchell Krassan, the Chief Strategy &#38; Performance Officer of the Company, terminated his previously announced
10b5-1 trading plan (the &#8220;Krassan 10b5-1 Plan&#8221;). The Krassan 10b5-1 Plan was originally entered into in December 2019
with respect to an aggregate of 789,658 ten-year options to acquire common stock, $0.001 per share, of the Company, with exercise
prices equal to $0.19 and $0.20 per share. The options&#160;expire in May 2020 and September 2020.&#160; An aggregate of 489,658
options with an exercise price of $0.20 per share that expire in September 2020 were not sold under the Krassan 10b5-1 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 10%"><span style="font-size: 10pt"><b>Item 8.01</b></span></td>
    <td style="width: 90%"><span style="font-size: 10pt"><b>Other Events.</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Risk Factor</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is supplementing
the risk factors previously disclosed in its Annual Report on Form&#160;10-K&#160;for the year ended December 31, 2019, filed with
the U.S. Securities and Exchange Commission on February 24, 2020 (the &#8220;2019 Form 10-K&#8221;), with the following&#160;risk
factor:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>The Company&#8217;s
financial condition and results of operations for fiscal year 2020 and beyond may be materially adversely affected by the ongoing
COVID-19 (coronavirus) outbreak.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The outbreak of the novel
COVID-19 (coronavirus) has evolved into a global pandemic. COVID-19 has spread to many regions of the world, including the United
States and Europe. The full extent to COVID-19 impacts our business and operating results will depend on future developments that
are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19 and the
actions to contain COVID-19 or treat its impact, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">While the Company has developed
a comprehensive COVID-19 contingency plan designed to preserve the value of the Company&#8217;s investments in its sales and marketing
infrastructure, protect the Company&#8217;s balance sheet during this period of market disruption and meet the needs of the Company&#8217;s
patients and prescribers, including cost-containment and spending cuts in the second quarter of 2020 that can be extended through
the rest of the year depending on the evolution of COVID-19, the Company has suspended its previously announced 2020 financial
guidance due to the unknown impact of COVID-19 on the Company&#8217;s business and the rapidly evolving nature of the pandemic.
As a result of COVID-19, the Company will, among other things, (i) defer approximately $10 million in consumer and healthcare practitioner
marketing spending for ANNOVERA&#174; and IMVEXXY&#174;, (ii) make cuts of approximately $20 million in other planned expenses for
the year, (iii) negotiate lower fees and/or suspend services from non-critical third party vendors, (iv) implement a hiring freeze,
(v) delay or cancel any non-critical information technology projects and (vi) eliminate travel, entertainment, meeting and event
expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Although the Company currently
continues to have uninterrupted wholesale and retail distribution of its products and the Company does not anticipate a shortage
of its products due to COVID-19 at this time, disruptions may occur for the Company&#8217;s customers or suppliers that may materially
affect the Company&#8217;s ability to obtain supplies or other components for its products, manufacture additional products or
deliver inventory in a timely manner. This would result in lost sales, additional costs, or penalties, or damage to the Company&#8217;s
reputation. In addition, due to closures and restrictions on travel, the Company&#8217;s sales force is currently functioning largely
utilizing digital engagement tools and tactics and virtual detailing, which may be less effective than the Company&#8217;s ordinary
course sales and marketing programs. The Company may also require an increased level of working capital if it experiences extended
billing and collection cycles as a result of displaced employees at the Company, payors, revenue cycle management contractors,
or otherwise. The Company may also experience other unknown impacts from COVID-19 that cannot be predicted. Accordingly, disruptions
to the Company&#8217;s business as a result of COVID-19 could result in a material adverse effect on the Company&#8217;s business,
results of operations, financial condition and prospects in the near-term and beyond 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Forward-Looking Statements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Current Report on
Form 8-K may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating
to the Company&#8217;s objectives, plans and strategies as well as statements, other than historical facts, that address activities,
events or developments that the Company intends, expects, projects, believes or anticipates will or may occur in the future. These
statements are often characterized by terminology such as &#8220;believes,&#8221; &#8220;hopes,&#8221; &#8220;may,&#8221; &#8220;anticipates,&#8221;
&#8220;should,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;will,&#8221; &#8220;expects,&#8221; &#8220;estimates,&#8221;
&#8220;projects,&#8221; &#8220;positioned,&#8221; &#8220;strategy&#8221; and similar expressions and are based on assumptions and
assessments made in light of the Company&#8217;s management&#8217;s experience and perception of historical trends, current conditions,
expected future developments and other factors believed to be appropriate. Forward-looking statements in this Form 8-K are made
as of the date of this Form 8-K, and the Company undertakes no duty to update or revise any such statements, whether as a result
of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject
to risks and uncertainties, many of which are outside of the Company&#8217;s control. Important factors that could cause actual
results, developments and business decisions to differ materially from forward-looking statements are described in the sections
titled &#8220;Risk Factors&#8221; in the 2019 Form 10-K as well as this Form 8-K, and include the following: the effects of the
COVID-19 pandemic; the Company&#8217;s ability to maintain or increase sales of its products; the Company&#8217;s ability to develop
and commercialize IMVEXXY&#174;, ANNOVERA&#174;, BIJUVA&#174; and its hormone therapy drug candidates and obtain additional financing
necessary therefor; whether the Company will be able to comply with the covenants and conditions under its term loan facility,
including the conditions to draw an additional tranche thereunder and whether the lender will make such tranche available; the
potential of adverse side effects or other safety risks that could adversely affect the commercialization of the Company&#8217;s
current or future approved products or preclude the approval of the Company&#8217;s future drug candidates; whether the U.S. Food
and Drug Administration (FDA) will approve the efficacy supplement for the lower dose of BIJUVA; the Company&#8217;s ability to
protect its intellectual property, including with respect to the Paragraph IV notice letters the Company received regarding IMVEXXY
and BIJUVA; the length, cost and uncertain results of future clinical trials; the Company&#8217;s reliance on third parties to
conduct its manufacturing, research and development and clinical trials; the ability of the Company&#8217;s licensees to commercialize
and distribute the Company&#8217;s products; the ability of the Company&#8217;s marketing contractors to market ANNOVERA; the availability
of reimbursement from government authorities and health insurance companies for the Company&#8217;s products; the impact of product
liability lawsuits; the influence of extensive and costly government regulation; the volatility of the trading price of the Company&#8217;s
common stock and the concentration of power in its stock ownership.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 9.01</b></td><td><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(d) <i>Exhibits</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span style="text-decoration: underline">Exhibit Index</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: left; white-space: nowrap; vertical-align: bottom">
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Exhibit</b></p>
        <p style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0 0 1pt"><b>Number</b></p></td>
    <td>&#160;</td>
    <td style="white-space: nowrap">
        <p style="border-bottom: black 1pt solid; font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Description
        of Exhibit</b></p></td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="ex99-1.htm">99.1</a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="ex99-1.htm">Press Release from TherapeuticsMD, Inc., dated March 26, 2020, entitled &#8220;TherapeuticsMD Provides COVID-19-Related Business Update&#8221;.</a></td></tr>
<tr>
    <td style="white-space: nowrap; vertical-align: top">104</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document).</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.2pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.2pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td>&#160;</td>
    <td colspan="2" style="vertical-align: bottom">THERAPEUTICSMD, INC.</td></tr>
<tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 60%">Date:&#160;&#160;&#160;March 26, 2020</td>
    <td style="vertical-align: bottom; width: 4%; padding-left: 1.1pt">By:</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 36%; padding-left: 1.1pt"><i>/s/ Daniel A. Cartwright</i></td></tr>
<tr>
    <td>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
        <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td>&#160;</td>
    <td style="vertical-align: top">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Daniel A. Cartwright</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Financial Officer</p></td></tr>
</table>
<p style="font: 2pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: center"><td style="width: 25%; white-space: nowrap"></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwkAMRU/QO4RZS21H6qI7LSpiFSkibgebymA7KZmx6pG8pdMWMQRC8v/LF2IiNrTWNTJclkUOJ2zaWjmEAitkNFf0jmy7S8HPAm/aOlbGDesPzMgz6JkklMrfB2enLZYpRLOpnE9lBLFMkxks9iLo9YxMpUs0TqsalCnhyNSyRqf4PX44qRcZat5D0hnZajIpxGE0yh+QUSzhQJ16Et8t5HkmgslQgdgwPdo+5mEdNbCqsfFZdkT/HXwB0zdJBw== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><A HREF="txmd-8k_032620.htm">TherapeuticsMD, Inc. 8-K</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><IMG SRC="ex99-1_img001.jpg" ALT="" STYLE="height: 31px; width: 270px"></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 88.9pt 0 0"><B>FOR IMMEDIATE RELEASE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.3pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.3pt; text-align: center"><B>TherapeuticsMD Provides COVID-19-Related
Business Update</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">- Strong preliminary first quarter 2020 total
net revenue projected to be more than $11 million &ndash;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">- vitaCare Prescription Services model allowing
the Company to connect with more than 80% of patients -</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">- Implementing staged contingency plan that
can be adjusted as COVID-19 situation evolves -</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>BOCA RATON, Fla.</B> &ndash; March 26, 2020
&ndash; TherapeuticsMD, Inc. (NASDAQ: TXMD) (&ldquo;TherapeuticsMD&rdquo; or the &ldquo;Company&rdquo;), an innovative, leading
women&rsquo;s healthcare company, today provided an update on its operations in response to the continued spread of COVID-19 (coronavirus)
pandemic. The Company has developed a comprehensive COVID-19 contingency plan designed to preserve the value of the Company&rsquo;s
investments in its sales and marketing infrastructure, protect the Company&rsquo;s balance sheet during this period of market disruption,
and meet the needs of the Company&rsquo;s patients and prescribers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">TherapeuticsMD&rsquo;s COVID-19 contingency
plan is designed to be implemented in stages over the second and third quarters of 2020 as the Company continues to evaluate the
length of time that COVID-19 may impact its business, allowing the Company to conserve its financial resources during the COVID-19
crisis and re-scale its sales and marketing activity when conditions warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&ldquo;The health and safety of our employees,
patients, prescribers, and community are paramount at this time,&rdquo; <FONT STYLE="background-color: white">said Robert G. Finizio,
Chief Executive Officer of TherapeuticsMD.</FONT> &ldquo;We have taken a swift and proactive approach to reduce our near-term cash
burn and provide for maximum flexibility to reinitiate our launch plans once we have more visibility on the length of the COVID-19
crisis,&rdquo; <FONT STYLE="background-color: white">said Mr. Finizio. &ldquo;While we believe we were on track with executing
our plan for 2020, including being able to deliver a better-than-planned first quarter, given the uncertainties around COVID-19,
we feel it is in the best interests of our Company and our stockholders to temporarily scale down certain aspects of our business
to preserve cash during this pandemic. We plan to leverage our best-in-class vitaCare Prescription Services patient model to continue
to meet the needs of our patients and </FONT>prescribers during this difficult time. Our highly-trained sales force remains engaged
with prescribers so that we ca<FONT STYLE="background-color: white">n ramp-up our sales efforts at the appropriate time.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">TherapeuticsMD&rsquo;s COVID-19 contingency
plan focuses on five key areas:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT>&nbsp;</TD><TD STYLE="text-align: justify">Containing costs and cutting spending.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">Addressing impacts and trends for the second quarter of 2020.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">Preparing for a potential longer-term impact throughout the year.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">Leveraging vitaCare Prescription Services <FONT STYLE="background-color: white">to continue to
meet the needs of our patients and </FONT>prescribers.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">Ensuring continued availability of our products to patients.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Cost Containment and Spending Cuts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">TherapeuticsMD is implementing measures
to initially cut or defer more than $30 million in annual spending. This includes the deferral of approximately $10 million in
planned second quarter consumer and healthcare practitioner marketing spend for ANNOVERA&reg; and IMVEXXY&reg; and cuts of approximately
$20 million in other planned expenses for the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">The Company has the ability to re-accelerate
its planned marketing spend for ANNOVERA and IMVEXXY should market conditions improve, or to extend or expand the cost deferrals
throughout the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">The Company&rsquo;s cost cuts and
reductions include permanent cost savings that have been identified by management, as well as the interim cessation of certain
spending that may be restarted in future quarters. These cost cuts include:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">Negotiating lower fees or suspending services from third party vendors;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">Implementing a Company-wide hiring freeze;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">Delaying or cancelling non-critical IT projects; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">Eliminating travel, entertainment, meeting, and event expenses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 5.15pt 0 0; text-align: justify">These savings can be extended further
throughout the year or expanded depending on the impact of the COVID-19 outbreak.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Employees and Sales Force</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At present, the Company&rsquo;s sales force
continues to function <FONT STYLE="background-color: white">utilizing digital engagement tools and tactics and virtual detailing
to remain engaged with prescribers and distribution channels</FONT>.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">The Company has enhanced the ability of its sales force to support healthcare providers remotely,
including the sales forces&#146; ability to continue to provide healthcare practitioners with access to patient product samples,
product marketing information, and information regarding patient affordability programs and support services.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">The Company&#146;s sales force is in regular interaction with healthcare providers and also continues
product training, including sharing best practices, in advance of the Company&#146;s anticipated future sales and marketing ramp.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Remote Pharmacy and At-Home Delivery Options</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">TherapeuticsMD is prepared to provide continued
access to its products for patients.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">The Company&#146;s vitaCare Prescription Services patient model assists patients in obtaining easy
and convenient access to their prescriptions for products at a retail pharmacy of their choice, including via home delivery retail
pharmacy options. The Company anticipates that home delivery pharmacy options will be attractive to patients during the COVID-19
pandemic.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">Through vitaCare, the Company has connected with more than 80% of its patients during the past
month. The Company anticipates that vitaCare will support continued patient access to the Company&#146;s products during the COVID-19
pandemic and will help sustain the Company&#146;s strong refill trends given vitaCare&#146;s broad use by the Company&#146;s patients.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD STYLE="text-align: justify">The Company has also partnered with independent community pharmacies and multiple third-party online
pharmacies (such as PillPack, PillClub, and Simple Health) and telemedicine providers (such as PlushCare) that focus on contraception
or menopause to help ensure patients have real-time access to both diagnosis and treatment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Supply of Products</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">TherapeuticsMD does not anticipate a shortage
of its products due to COVID-19 at this time.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD>The company already has sufficient inventory of finished product in its warehouses to meet anticipated demand through at least
early third quarter of this year.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD>Additionally, the Company currently does not foresee any interruption in its ability to continue to manufacture additional
product to be used beyond this period and has sufficient active pharmaceutical ingredients on hand for the continued manufacture
of its products.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 8pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 6pt">&#9632;</FONT></TD><TD>At this time, the Company continues to have uninterrupted wholesale and retail distribution of its products and is actively
working to ensure that there continues to be an adequate supply of its products at pharmacies for sales to patients.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Suspending
2020 Financial Guidance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">Due to
the unknown impact of COVID-19 on the Company&rsquo;s business and the rapidly evolving nature of the pandemic, TherapeuticsMD
is suspending its full-year 2020 financial guidance that was previously provided in February 2020. The Company&rsquo;s January
and February operating results were ahead of the internal forecasts that were included in the Company&rsquo;s full-year guidance.
Together with March operating results that will be partially affected by the COVID-19 outbreak in the U.S., the Company projects
that preliminary first quarter net revenues will be more than $11 million. </FONT> The Company believes that its vitaCare Prescription
Services patient model will support continued patient access to the Company&rsquo;s products during the COVID-19 pandemic and will
help sustain the Company&rsquo;s strong refill trends across its menopause products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="background-color: white">The foregoing
amount is unaudited and preliminary, and does not present all information necessary for an understanding of the Company&rsquo;s
financial condition as of March 31, 2020. The review of the Company&rsquo;s consolidated financial statements for the three months
ending March 31, 2020 has not commenced and could result in changes to this amounts due to the completion of financial closing
procedures, final adjustments and other developments that may arise between now and the time the consolidated financial statements
for the three months ended March 31, 2020 are finalized and publicly released. The Company&rsquo;s independent registered public
accounting firm, Grant Thornton LLP, has not audited, reviewed, or compiled this estimate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>About TherapeuticsMD</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">TherapeuticsMD, Inc. is an innovative, leading
healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to
address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in
family planning, reproductive health, and menopause management. The Company is committed to advancing the health of women and championing
awareness of their healthcare issues. To learn more about TherapeuticsMD, please visit www.therapeuticsmd.com or follow us on Twitter:
@TherapeuticsMD and on Facebook: TherapeuticsMD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This press release by TherapeuticsMD, Inc.
may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to
TherapeuticsMD&rsquo;s objectives, plans and strategies as well as statements, other than historical facts, that address activities,
events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future. These
statements are often characterized by terminology such as &quot;believes,&quot; &quot;hopes,&quot; &quot;may,&quot; &quot;anticipates,&quot;
&quot;should,&quot; &quot;intends,&quot; &quot;plans,&quot; &quot;will,&quot; &quot;expects,&quot; &quot;estimates,&quot; &quot;projects,&quot;
&quot;positioned,&quot; &quot;strategy&quot; and similar expressions and are based on assumptions and assessments made in light
of management&rsquo;s experience and perception of historical trends, current conditions, expected future developments and other
factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release,
and the company undertakes no duty to update or revise any such statements, whether as a result of new information, future events
or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many
of which are outside of the company&rsquo;s control. Important factors that could cause actual results, developments and business
decisions to differ materially from forward-looking statements are described in the sections titled &quot;Risk Factors&quot; in
the company&rsquo;s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and
Quarterly Reports on Form 10-Q, as well as reports on Form 8-K, and include the following: the effects of the COVID-19 pandemic;
the company&rsquo;s ability to maintain or increase sales of its products; the company&rsquo;s ability to develop and commercialize
IMVEXXY&reg;, ANNOVERA&reg;, BIJUVA&reg; and its hormone therapy drug candidates and obtain additional financing necessary therefor;
whether the company will be able to comply with the covenants and conditions under its term loan facility, including the conditions
to draw an additional tranche thereunder and whether the lender will make such tranche available; the potential of adverse side
effects or other safety risks that could adversely affect the commercialization of the company&rsquo;s current or future approved
products or preclude the approval of the company&rsquo;s future drug candidates; whether the FDA will approve the efficacy supplement
for the lower dose of BIJUVA; the company&rsquo;s ability to protect its intellectual property, including with respect to the Paragraph
IV notice letters the company received regarding IMVEXXY and BIJUVA; the length, cost and uncertain results of future clinical
trials; the company&rsquo;s reliance on third parties to conduct its manufacturing, research and development and clinical trials;
the ability of the company&rsquo;s licensees to commercialize and distribute the company&rsquo;s products; the ability of the company&rsquo;s
marketing contractors to market ANNOVERA; the availability of reimbursement from government authorities and health insurance companies
for the company&rsquo;s products; the impact of product liability lawsuits; the influence of extensive and costly government regulation;
the volatility of the trading price of the company&rsquo;s common stock and the concentration of power in its stock ownership.
PDF copies of the company&rsquo;s historical press releases and financial tables can be viewed and downloaded at it website: www.therapeuticsmd.com/pressreleases.aspx.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"># # #</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5.35pt; text-indent: -5.35pt"><B><U>Investor Contact</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nichol Ochsner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Vice President, Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">561-961-1900, ext. 2088</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nochsner@TherapeuticsMD.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 25%; white-space: nowrap"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>txmd-20200326.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6spw7xRiXhun8uCbn1MSaCBybP9w5dzSelBtm9xHRm6TyUpPzdcvSg75XTW8cAN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:TXMD="http://therapeuticsmd.com/20200326" elementFormDefault="qualified" targetNamespace="http://therapeuticsmd.com/20200326">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://therapeuticsmd.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="txmd-20200326_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="txmd-20200326_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>txmd-20200326_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>txmd-20200326_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.2a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://therapeuticsmd.com/role/Cover" xlink:href="txmd-20200326.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://therapeuticsmd.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex99-1_img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ? 0X# 2(  A$! Q$!_\0
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M^['*K'\@:FFGAMX]\\J1)G&YV"C]:\-\0:1\/8M)FO?"^N+::K:KYL.VX?\
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;RK_<'.%_4_Y%=/1142DY.[.FE25*"A'H?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="txmd-8k_032620.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://therapeuticsmd.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="txmd-8k_032620.htm">txmd-8k_032620.htm</File>
    <File>ex99-1.htm</File>
    <File>txmd-20200326.xsd</File>
    <File>txmd-20200326_lab.xml</File>
    <File>txmd-20200326_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>9
<FILENAME>0001387131-20-003271-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001387131-20-003271-xbrl.zip
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M[4:9_R^<4Y*,D^^!3BG<0D_*(!$,XQI*>,Z_9T1@5J45I!*!H5 2_K"R,Y%
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MHJ3>A9M@/A3J14A4+B&9RJ'U!YV')4-/3'N$)-(4J\ WA@T,PVYHJ6*:CI&
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ML_(!Q^;_ZYR9QWZ_UMU$T@S_ E!+ P04    " #=@'I0D]'#%S8+  ",B@
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M>KOC+")$/M&55>-7WU6[@=%NR7E7DYI,#0H-B+;W^ 4XW%>!:G4<U.8P_Y<
MY8/K,E<=BYX6CU@<QMMMGLF95=B#KZ-W!CF^03&@ <9MBHZ(@  <8!.Z95%$
MHB+T *E@5(OV>@Z7[3,=DOCSVSUY(%R^ ;$DN_RSV-U3QUG(@%C79WB#FV.>
M\/4&!H'B>]U"IX,9JE> 5O))M+(*]+NL!!6U^/EN>'U/I_&4%.'79(W36Z[R
MD0NO<6=V^*'AKN^ZO:=1YEVX(;%!8/H!P^!=NJJ. Z1J044U,KO4OB+H^>OZ
MIFOQ26S6F\2O%<Z(V/)?4$L#!!0    ( -V >E -(SL >@<  /9:   5
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MGT^WHV1&,Q(SX: EM+4IY6JI*]<].SOK%-]N3 \LEV/%-VV<=C;N;&NVW[*
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MP39__5M5W2U+LFP@,5GN\TQF)B#U6EW+KZJK6WO_.Q[:[$'X@>4Z[PK5<J7
MA&.XIN7TWQ6BL%?:*OSO_NK*WB"$<E#6"=X5!F'H[:RMC4:C\JA>=OW^6G5[
M>WMMC&4*LM#..+=<K5*IKGT]/>D8 S'D)<L)0NX8(JYD6\[=_/;Q;5RTZ]M6
MJB@^T9W4UV::AK?FM$*R\,::?)DJ&N8679=%0UW4"MQ&K;JY:!RR1%QA/*]L
M%<<,,Q1?#RY/IL7#_/+3HFNASYV@Y_I#'L(:8DOKI4JM5-M(-%(*A)%J"'XO
M]]V')]O9*M6KNIV9Q4G/%%]W>1!3W!09<NL^X06VOEVJ5!.M^Z(WM_&--7BK
M"T9!J<^Y%Q?N\:!+!=6+G+;AC>_:(LBM0V]R*AENY(3^)'\.ZB56VTQ7"_QP
MMAMXF-/#U=?3H[AL.! ^]T046D8P-,N&.X0:2%A82!) P4WXF^$_>Z$5VF)_
M;TW^#6^'(N0,6RJ)^\AZ>%<X=)U0.&'I:N+!BACRMW>%4(S#-2FG:U!?-;KW
M_THE=FP)V]QA'1'NLC,^%#ML;(YW6?N(?KBIU*HWUYV_:D?OF\T+^ NGPTJE
MY]:N']W@=&]FIWFCI_F"UAJ5N-;W5%]OW C@0I@%_-MR@(J30R"/S^VV8XKQ
M)S&YJ> _M?7-1OTE[6XGVFT.A6/"?^&QS?LW/6X'X@5-;1P M8]NJC=*@<@V
MX=%+VJC== ;<%\%-[8;TI6PDH&<O:><(QW*AVJK/#&ENXUW7G.#?IO7 @G!B
MBW<%TPH\FT]VF.,Z@AC;&N\@&PJ?N)M^M4Q3.(K9\0&4/8N&PK<,R<GC\!*U
MQ;'O#G'U2Y4ZJ+O0G?Y<8 [, WH3UD[N^A;VIPN\MY;JXL?ZE0KT70&4[D[7
M!=7"'5KZY(A2G%'8I_=S!K&6)@<."E2A\,%&BT 70LV[$Y!)A?$QLI,[ U*H
MX7AHEK2$E,>!65"O0] +[PJ!-?1L@;H@T5^F ]EGX$9^HDM:\1U%%&:9"XFB
MU9:N)FA%XJ?Q<\O$-SU+^(QF(W)-UF'[4WKULI6GW:WE]J=Z\X#.KCD["L -
M?GC$0[$_G8)N:?INIAHLZ9Q*^DUV6*D!Z(>*I&DZ1XXEB0S"-D/-H>!!Y(M]
M)94[4$8WIE^EN\#6YK0O17QN%XH(5.B[^YBJDIE^0$_ ,L[2%NN28/#0]1.O
M7TZ#[!CS6DUT>B0<=V@Y3W7[-%VR_>8UK-^GJ)!'T+49B91Z0FO1O35H O[&
M/WN>UKP]X*P=5JUX(;NRAJ"CS\2(7;I#[A3E@R)8 -_J[;(A]_N6L\,JNPQY
ML<1MJP^_&B!'PB\ ;/"H\:3MN(QL4;K@?3)Q27TOVRJ%KD?MJ5^[;ABZ0WHR
MLLQP@..J_%5(U>RZ/DQ'UCRPN7'':C#TP+4M<Y?A9$J!]0BVJNJ!V5*%=;NR
M?%67+^S_][^J&Y5=21CU_\3HUU+#?R6RZ2%XK]7!7G?_^JQ]U3IBG:OF5:NS
MM];=?]WN.JW#Z\OV5;O58<VS(];Z>OBA>?:^Q0[/3T_;G4[[_.SUQ_"%!P-P
M5D,7ZAZ5#\NL!O!N>VG]_IQU.SZ_/&5[@<<=4I&(NK8K1P0F2Z4CUX@0+2"4
MOS%BW#M%P(_G5[>1VS3-8%R'YGX4,"7[*^QOE3YEL<G>&HYT_P^C,;#J9>OL
MBEVV+LXOK_ZPP5]$?A!Q)V2A"Y4,]-!9M<Y<GU77WYAOF=MCX%G]!(D71N1;
MH06MM,;&@#N@,IM&B/U7M^N-/XFJB,EPW)?"<_V0O3'5[X*#O15!R,0#E&0^
MO1;FVQT8149"ZQD)O2!$UY)X+U]4G?7MQ\;CZ2?_\KLE->EBX*"'4&]@\LD$
M1BZ</$E.C:NP?\I]8\!J&T6&S<Z5[C]C&8$IYRV+]/PN1=\*,+@5HF^;ORI;
MMBV<D?/-&IA+4*!Y_1;VKQ*1C].C(FL[1OFU-6L^R=ZTQAQD%H<E!4 /E/&
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M2KZ"EB>I1(AXCD%W]A& 6V!:$CNZ/:F 7['_E(8@XY%FN85\^ O(=>@.AU:
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M.V9=8;LCG!^^1"JPK=(GUK-L(!RS M##H7!,8:ZN +H/K&%DA]P1;A38$Q;
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M%E7FN?)2;40(@M;9(DS)\]$$J$\P%SZ)1^3CUL\LDL3%Z_M\F-D@Q9ZX';A
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M]D<7IOL_Z\.6>=8]O ]ZQ]_,NZNU#U]'!Y5'\^/!Z-T[29+_#U!+ 0(4 Q0
M   ( -V >E".A,^W9!@  )5G   *              "  0    !E>#DY+3$N
M:'1M4$L! A0#%     @ W8!Z4%F76V%+ P  H0P  !$              ( !
MC!@  '1X;60M,C R,# S,C8N>'-D4$L! A0#%     @ W8!Z4)/1PQ<V"P
MC(H  !4              ( !!AP  '1X;60M,C R,# S,C9?;&%B+GAM;%!+
M 0(4 Q0    ( -V >E -(SL >@<  /9:   5              "  6\G  !T
M>&UD+3(P,C P,S(V7W!R92YX;6Q02P$"% ,4    " #=@'I06Z0TP?,?  "1
MD0  $@              @ $<+P  ='AM9"TX:U\P,S(V,C N:'1M4$L%!@
0   %  4 /0$  #]/      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>txmd-8k_032620_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="txmd-20200326.xsd" xlink:type="simple"/>
    <context id="From2020-03-26to2020-03-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000025743</identifier>
        </entity>
        <period>
            <startDate>2020-03-26</startDate>
            <endDate>2020-03-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-03-26to2020-03-26">0000025743</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-03-26to2020-03-26">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2020-03-26to2020-03-26">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-03-26to2020-03-26">2020-03-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2020-03-26to2020-03-26">TherapeuticsMD, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-03-26to2020-03-26">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-03-26to2020-03-26">001-00100</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-03-26to2020-03-26">87-0233535</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-03-26to2020-03-26">951 Yamato Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine1 contextRef="From2020-03-26to2020-03-26">951 Yamato Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2020-03-26to2020-03-26">Suite 220</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2020-03-26to2020-03-26">Boca Raton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-03-26to2020-03-26">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-03-26to2020-03-26">33431</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-03-26to2020-03-26">(561)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-03-26to2020-03-26">961-1900</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName contextRef="From2020-03-26to2020-03-26">Not Applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications contextRef="From2020-03-26to2020-03-26">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-03-26to2020-03-26">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-03-26to2020-03-26">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-03-26to2020-03-26">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-03-26to2020-03-26">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-03-26to2020-03-26">TXMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-03-26to2020-03-26">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-03-26to2020-03-26">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+""
MWTG] E!+ P04    " #=@'I0@GF-H^X    K @  $0   &1O8U!R;W!S+V-O
M<F4N>&ULS9+/:L,P#(=?9?B>R$E*#B;-I6.G#08K;.QF;+4UB_]@:R1]^R5>
MFS*V!]C1TL^?/H$Z%83R$9^C#QC)8+J;[."24&'+3D1! "1U0BM3.2?<W#SX
M:"7-SWB$(-6'/"+4G+=@D:26)&$!%F$ELK[32JB(DGR\X+5:\>$S#AFF%>"
M%ATEJ,H*6+],#.=IZ. &6&"$T:;O NJ5F*M_8G,'V"4Y);.FQG$LQR;GYATJ
M>'MZ?,GK%L8EDD[A_"L90>> 6W:=_-KL[O</K*]YS0O>%'6[KUK!6['9O"^N
M/_QNPM9K<S#_V/@JV'?PZR[Z+U!+ P04    " #=@'I0F5R<(Q &  "<)P
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M&HC*@F76_D&"BN58&![J^;@)]R)LUR"-2(YB*;E$N(4'W-E4Z/&[5Y>=&H2
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MZ<&8A6#O[I5TXH\<P_?,?P!02P,$%     @ W8!Z4/_ )@B]    A0(  !H
M  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<ZV200J#,!  OR)Y0%=MZ:&H
MIUZ\MOU T-6(FH3LENKOFWI10:$'+PEAP\Q DCRPD]P83:JQ% Q]IRD5BMG>
M *A0V$LZ&8O:3RKC>LG^Z&JPLFAEC1"'X17<DB&R9,D,\C(5+B\C$;RDJY%3
M 4,''^-:4HA,,&W1R0O\E='B/WI354V!=U.\>]2\43$+!&P'Q7,0*>FP?+)K
M=$U'AZS@>S'G10R/'1Y?,5'W])=9SUZ",*V'O\E$_37 ZM=E7U!+ P04
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MH%W\S<A'2NU!7PW_R?(+4$L! A0#%     @ W8!Z4!\CSP/     $P(   L
M             ( !     %]R96QS+RYR96QS4$L! A0#%     @ W8!Z4"?H
MAPZ"    L0   !               ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q0
M2P$"% ,4    " #=@'I0@GF-H^X    K @  $0              @ &9 0
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #=@'I0F5R<(Q &  "<)P
M$P              @ &V @  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( -V >E"? )L)M@(  %\,   8              "  ?<(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #=@'I0-MD1+(0"  "0!@
M%               @ 'C"P  >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4
M    " #=@'I0NJ$YBM<!   R!@  #0              @ &9#@  >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( -V >E P _>^-P$  "("   /
M  "  9L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #=@'I0_\ F"+T
M  "% @  &@              @ '_$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " #=@'I0"X_8 R$!  !7!   $P
M@ 'T$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "@ * ( "  !&%
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6608444224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 26,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-00100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TherapeuticsMD, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000025743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0233535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">951 Yamato Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boca Raton<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">961-1900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TXMD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not Applicable<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "txmd-8k_032620.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "txmd-8k_032620.htm"
     ]
    },
    "labelLink": {
     "local": [
      "txmd-20200326_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "txmd-20200326_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "txmd-20200326.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 60,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "TXMD",
   "nsuri": "http://therapeuticsmd.com/20200326",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "txmd-8k_032620.htm",
      "contextRef": "From2020-03-26to2020-03-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://therapeuticsmd.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "txmd-8k_032620.htm",
      "contextRef": "From2020-03-26to2020-03-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in CCYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://therapeuticsmd.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r11": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r13": {
   "Name": "Forms 10-K, 20-F, 40-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d-1"
  },
  "r14": {
   "Name": "Forms 20-F, 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220 and 240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
